12/13/24 16:04 | 12/11/24 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | | M.d | 4 | 18.09 | 0 | 0 | 1 | 15 | D | | | | | | | | | | | | | | |
12/13/24 16:04 | 12/11/24 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | | S.d | -9 | 46.28 | 0 | 0 | -1 | 15 | D | | | | | | | | | | | | | | |
6/17/24 17:18 | 6/13/24 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | | M.d | 0 | 0.00 | 0 | 3 | 28 | 15 | D | | | | | | | | | | | | | | |
6/23/23 16:36 | 6/21/23 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | | M.d | 0 | 0.00 | 0 | 5 | 70 | 12 | D | | | | | | | | | | | | | | |
5/24/22 16:12 | 5/20/22 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | | M.d | 0 | 0.00 | 0 | 2 | 29 | 7 | D | | | | | | | | | | | | | | |
6/2/21 16:07 | 5/28/21 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | | M.d | 0 | 0.00 | 0 | 2 | 44 | 6 | D | | | | | | | | | | | | | | |
6/1/20 17:14 | 5/29/20 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | | M.d | 0 | 0.00 | 0 | 2 | 95 | 4 | D | | | | | | | | | | | | | | |
5/31/19 16:08 | 5/31/19 | AGIO | Agios Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | | M.d | 0 | 0.00 | 0 | 1 | 245 | 2 | D | | | | | | | | | | | | | | |
6/27/18 16:36 | 6/25/18 | MGTA | Magenta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | | P.d | 99 | 15.00 | 0 | 7 | 1 | 809 | D | | | | | | | | | | | | | | |
3/20/18 16:43 | 3/16/18 | AGIO | Agios Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | | P | 17 | 83.44 | 0 | 0 | 54 | 1 | D | | | | | | | | | | | | | | |